205 related articles for article (PubMed ID: 22041830)
1. Renal failure in chronic liver disease and the hepatorenal syndrome.
Srivastava B; Alexander GJ
Br J Hosp Med (Lond); 2011 Sep; 72(9):497-503. PubMed ID: 22041830
[No Abstract] [Full Text] [Related]
2. Treatment of the hepatorenal syndrome and hyponatremia in cirrhosis - part II.
Møller S; Aagaard NK; Schmidt L; Grønbaek H; Hansen JB; Bendtsen F
Dan Med J; 2012 Jan; 59(1):C4372. PubMed ID: 22239848
[TBL] [Abstract][Full Text] [Related]
3. [Renal impairment in liver diseases].
Gerbes AL; Gülberg V
Praxis (Bern 1994); 2006 Oct; 95(40):1535-8. PubMed ID: 17048410
[TBL] [Abstract][Full Text] [Related]
4. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
[TBL] [Abstract][Full Text] [Related]
5. [Hepatorenal syndrome: diagnosis, treatment and prevention].
Egerod Israelsen M; Gluud LL; Bendtsen F; Møller S; Krag AA
Ugeskr Laeger; 2013 May; 175(22):1562-6. PubMed ID: 23721840
[TBL] [Abstract][Full Text] [Related]
6. Long-term terlipressin administration improves renal function in cirrhotic patients with type 1 hepatorenal syndrome: a pilot study.
Mulkay JP; Louis H; Donckier V; Bourgeois N; Adler M; Deviere J; Le Moine O
Acta Gastroenterol Belg; 2001; 64(1):15-9. PubMed ID: 11322061
[TBL] [Abstract][Full Text] [Related]
7. [The modern possibilities of the hepato-renal syndrome treatment].
Blokhina NV; Pasechnik IN
Khirurgiia (Mosk); 2013; (8):81-5. PubMed ID: 24344429
[No Abstract] [Full Text] [Related]
8. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.
Boyer TD; Sanyal AJ; Wong F; Frederick RT; Lake JR; O'Leary JG; Ganger D; Jamil K; Pappas SC;
Gastroenterology; 2016 Jun; 150(7):1579-1589.e2. PubMed ID: 26896734
[TBL] [Abstract][Full Text] [Related]
9. Targeting circulatory dysfunction in cirrhosis: terlipressin and the hepatorenal syndrome.
Testro AG; Angus PW
J Gastroenterol Hepatol; 2009 Nov; 24(11):1707-9. PubMed ID: 20136956
[No Abstract] [Full Text] [Related]
10. Hepatorenal syndrome.
Cárdenas A; Uriz J; Ginès P; Arroyo V
Liver Transpl; 2000 Jul; 6(4 Suppl 1):S63-71. PubMed ID: 10915194
[No Abstract] [Full Text] [Related]
11. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.
Arroyo V; Terra C; Ginès P
J Hepatol; 2007 May; 46(5):935-46. PubMed ID: 17391801
[No Abstract] [Full Text] [Related]
12. Hepatorenal syndrome in patients with cirrhosis.
Moreau R
J Gastroenterol Hepatol; 2002 Jul; 17(7):739-47. PubMed ID: 12121502
[TBL] [Abstract][Full Text] [Related]
13. Terlipressin in hepatorenal syndrome: Evidence for present indications.
Rajekar H; Chawla Y
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():109-14. PubMed ID: 21199521
[TBL] [Abstract][Full Text] [Related]
14. Acute kidney injury and hepatorenal syndrome in cirrhosis.
Egerod Israelsen M; Gluud LL; Krag A
J Gastroenterol Hepatol; 2015 Feb; 30(2):236-43. PubMed ID: 25160511
[TBL] [Abstract][Full Text] [Related]
15. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
Martín-Llahí M; Pépin MN; Guevara M; Díaz F; Torre A; Monescillo A; Soriano G; Terra C; Fábrega E; Arroyo V; Rodés J; Ginès P;
Gastroenterology; 2008 May; 134(5):1352-9. PubMed ID: 18471512
[TBL] [Abstract][Full Text] [Related]
16. Renal failure in cirrhotic patients: role of terlipressin in clinical approach to hepatorenal syndrome type 2.
Alessandria C; Venon WD; Marzano A; Barletti C; Fadda M; Rizzetto M
Eur J Gastroenterol Hepatol; 2002 Dec; 14(12):1363-8. PubMed ID: 12468959
[TBL] [Abstract][Full Text] [Related]
17. Hepatorenal syndrome: Current concepts related to diagnosis and management.
de Mattos ÁZ; de Mattos AA; Méndez-Sánchez N
Ann Hepatol; 2016; 15(4):474-81. PubMed ID: 27236146
[TBL] [Abstract][Full Text] [Related]
18. Review article: pharmacological treatment of the hepatorenal syndrome in cirrhotic patients.
Dagher L; Patch D; Marley R; Moore K; Burroughs A
Aliment Pharmacol Ther; 2000 May; 14(5):515-21. PubMed ID: 10792112
[TBL] [Abstract][Full Text] [Related]
19. Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome.
Neri S; Pulvirenti D; Malaguarnera M; Cosimo BM; Bertino G; Ignaccolo L; Siringo S; Castellino P
Dig Dis Sci; 2008 Mar; 53(3):830-5. PubMed ID: 17939047
[TBL] [Abstract][Full Text] [Related]
20. Is spontaneous bacterial peritonitis an inducer of vasopressin analogue side-effects? A case report.
Vaccaro F; Giorgi A; Riggio O; De Santis A; Laviano A; Rossi-Fanelli F
Dig Liver Dis; 2003 Jul; 35(7):503-6. PubMed ID: 12870738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]